JNJ Johnson & Johnson revenue, earnings and financials

For the quarter ended September 27, 2026, Johnson & Johnson reported revenue of $25.4B (up 5.9% from a year earlier), net income of $210M and diluted EPS of $0.09; over the last four quarters revenue was $99.3B and net income $16.1B; for the fiscal year ended December 2025 revenue was $94.2B, up 6.0% on the year before.

JNJ annual revenue and earnings

• Fiscal year ended Dec 2025: revenue $94.2B, gross profit $63.9B, operating income n/a, net income $26.8B (margin 28.5%), EPS $11.03
• Fiscal year ended Dec 2024: revenue $88.8B, gross profit $61.4B, operating income n/a, net income $14.1B (margin 15.8%), EPS $5.79
• Fiscal year ended Dec 2023: revenue $85.2B, gross profit $58.6B, operating income n/a, net income $35.2B (margin 41.3%), EPS $13.72
• Fiscal year ended Jan 2023: revenue $80.0B, gross profit $55.4B, operating income n/a, net income $17.9B (margin 22.4%), EPS $6.73
• Fiscal year ended Jan 2022: revenue $78.7B, gross profit $55.3B, operating income n/a, net income $20.9B (margin 26.5%), EPS $7.81

JNJ quarterly revenue and earnings

• Quarter ended Sep 27, 2026: revenue $25.4B (up 5.9% year over year), net income $210M, EPS $0.09
• Quarter ended Jun 28, 2026: revenue $25.3B (up 6.6% year over year), net income $5.53B, EPS $2.27
• Quarter ended Mar 29, 2026: revenue $24.1B (up 9.9% year over year), net income $5.24B, EPS $2.14
• Quarter ended Dec 28, 2025 (from the annual report): revenue $24.6B (up 9.1% year over year), net income $5.12B, EPS $2.08
• Quarter ended Sep 28, 2025: revenue $24.0B (up 6.8% year over year), net income $5.15B, EPS $2.12
• Quarter ended Jun 29, 2025: revenue $23.7B (up 5.8% year over year), net income $5.54B, EPS $2.29
• Quarter ended Mar 30, 2025: revenue $21.9B (up 2.4% year over year), net income $11.0B, EPS $4.54
• Quarter ended Dec 29, 2024 (from the annual report): revenue $22.5B (up 5.3% year over year), net income $3.43B, EPS $1.41
• Quarter ended Sep 29, 2024: revenue $22.5B (up 5.2% year over year), net income $2.69B, EPS $1.11
• Quarter ended Jun 30, 2024: revenue $22.4B (up 4.3% year over year), net income $4.69B, EPS $1.93
• Quarter ended Mar 31, 2024: revenue $21.4B (up 2.3% year over year), net income $3.26B, EPS $1.34
• Quarter ended Dec 31, 2023: revenue $21.4B (up 7.3% year over year), net income $4.05B, EPS $1.67
• Quarter ended Oct 1, 2023: revenue $21.4B (up 6.8% year over year), net income $26.0B, EPS $10.21
• Quarter ended Jul 2, 2023: revenue $21.5B (up 6.5% year over year), net income $5.14B, EPS $1.96
• Quarter ended Apr 2, 2023: revenue $20.9B (up 5.3% year over year), net income −$68.0M, EPS −$0.03
• Quarter ended Jan 1, 2023: revenue $19.9B (up 104.1% year over year), net income $3.52B, EPS $1.33
• Quarter ended Oct 2, 2022: revenue $20.0B (down 14.3% year over year), net income $4.46B, EPS $1.68
• Quarter ended Jul 3, 2022: revenue $20.2B (down 13.3% year over year), net income $4.81B, EPS $1.80
• Quarter ended Apr 3, 2022: revenue $19.8B (down 11.1% year over year), net income $5.15B, EPS $1.93
• Quarter ended Jan 2, 2022 (from the annual report): revenue $9.77B, net income $4.74B, EPS $1.77

JNJ cash flow, buybacks and dividends

• Fiscal year ended Dec 2025: operating cash flow $24.5B, share buybacks $5.95B
• Fiscal year ended Dec 2024: operating cash flow $24.3B, share buybacks $2.43B
• Fiscal year ended Dec 2023: operating cash flow $22.8B, share buybacks $5.05B
• Fiscal year ended Jan 2023: operating cash flow $21.2B, share buybacks $6.04B
• Fiscal year ended Jan 2022: operating cash flow $23.4B, share buybacks $3.46B

JNJ balance sheet

• Sep 27, 2026: cash $16.9B, total assets $197B, total liabilities $116B, shareholders' equity $81.5B, long-term debt $35.8B
• Jun 28, 2026: cash $20.4B, total assets $201B, total liabilities $116B, shareholders' equity $85.0B, long-term debt $37.3B
• Mar 29, 2026: cash $21.7B, total assets $201B, total liabilities $120B, shareholders' equity $81.2B, long-term debt $37.5B
• Dec 28, 2025: cash $19.7B, total assets $199B, total liabilities $118B, shareholders' equity $81.5B, long-term debt $39.4B
• Sep 28, 2025: cash $18.2B, total assets $193B, total liabilities $114B, shareholders' equity $79.3B, long-term debt $39.4B
• Jun 29, 2025: cash $18.6B, total assets $193B, total liabilities $115B, shareholders' equity $78.5B, long-term debt $39.2B
• Mar 30, 2025: cash $38.5B, total assets $194B, total liabilities $116B, shareholders' equity $78.1B, long-term debt $38.4B
• Dec 29, 2024: cash $24.1B, total assets $180B, total liabilities $109B, shareholders' equity $71.5B, long-term debt $30.7B

What is JNJ's revenue?

Johnson & Johnson reported $99.3B of revenue over its last four quarters, through September 27, 2026.

Is JNJ profitable?

Yes. Johnson & Johnson earned $16.1B over the last four quarters.

What is JNJ's EPS?

Diluted earnings per share over the last four quarters were $6.58; $0.09 in the latest quarter.

JNJ ownership and insider trades · All stocks